Literature DB >> 23494448

Systematic evaluation of validated type 2 diabetes and glycaemic trait loci for association with insulin clearance.

M O Goodarzi1, X Guo, J Cui, M R Jones, T Haritunians, A H Xiang, Y-D I Chen, K D Taylor, T A Buchanan, W A Hsueh, L J Raffel, J I Rotter.   

Abstract

AIMS/HYPOTHESIS: Insulin clearance is a highly heritable trait, for which few quantitative trait loci have been discovered. We sought to determine whether validated type 2 diabetes and/or glycaemic trait loci are associated with insulin clearance.
METHODS: Hyperinsulinaemic-euglycaemic clamps were performed in two Hispanic-American family cohorts totalling 1329 participants in 329 families. The Metabochip was used to fine-map about 50 previously identified loci for type 2 diabetes, fasting glucose, fasting insulin, 2 h glucose or HbA1c. This resulted in 17,930 variants, which were tested for association with clamp-derived insulin clearance via meta-analysis of the two cohorts.
RESULTS: In the meta-analysis, 38 variants located within seven loci demonstrated association with insulin clearance (p < 0.001). The top signals for each locus were rs10241087 (DGKB/TMEM195 [TMEM195 also known as AGMO]) (p = 4.4 × 10(-5)); chr1:217605433 (LYPLAL1) (p = 3.25 × 10(-4)); rs2380949 (GLIS3) (p = 3.4 × 10(-4)); rs55903902 (FADS1) (p = 5.6 × 10(-4)); rs849334 (JAZF1) (p = 6.4 × 10(-4)); rs35749 (IGF1) (p = 6.7 × 10(-4)); and rs9460557 (CDKAL1) (p = 6.8 × 10(-4)). CONCLUSIONS/
INTERPRETATION: While the majority of validated loci for type 2 diabetes and related traits do not appear to influence insulin clearance in Hispanics, several of these loci do show evidence of association with this trait. It is therefore possible that these loci could have pleiotropic effects on insulin secretion, insulin sensitivity and insulin clearance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23494448      PMCID: PMC3651757          DOI: 10.1007/s00125-013-2880-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  56 in total

1.  Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans.

Authors:  S M Haffner; M P Stern; R M Watanabe; R N Bergman
Journal:  Eur J Clin Invest       Date:  1992-03       Impact factor: 4.686

2.  Evidence for joint genetic control of insulin sensitivity and systolic blood pressure in hispanic families with a hypertensive proband.

Authors:  A H Xiang; S P Azen; L J Raffel; S Tan; L S Cheng; J Diaz; E Toscano; P C Henderson; H N Hodis; W A Hsueh; J I Rotter; T A Buchanan
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

3.  The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.

Authors:  D Altshuler; J N Hirschhorn; M Klannemark; C M Lindgren; M C Vohl; J Nemesh; C R Lane; S F Schaffner; S Bolk; C Brewer; T Tuomi; D Gaudet; T J Hudson; M Daly; L Groop; E S Lander
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

4.  Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients.

Authors:  Natalia N Rudovich; Helmut J Rochlitz; Andreas F H Pfeiffer
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

Review 5.  Insulin degradation: progress and potential.

Authors:  W C Duckworth; R G Bennett; F G Hamel
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

6.  GLIS3, a novel member of the GLIS subfamily of Krüppel-like zinc finger proteins with repressor and activation functions.

Authors:  Yong-Sik Kim; Gen Nakanishi; Mark Lewandoski; Anton M Jetten
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

7.  Desaturation and elongation of Fatty acids and insulin action.

Authors:  B Vessby; I-B Gustafsson; S Tengblad; M Boberg; A Andersson
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

8.  Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans.

Authors:  K Osei; D P Schuster
Journal:  Diabet Med       Date:  1994-10       Impact factor: 4.359

9.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

10.  Increased insulin clearance in peroxisome proliferator-activated receptor gamma2 Pro12Ala.

Authors:  Otto Tschritter; Andreas Fritsche; Norbert Stefan; Michael Haap; Claus Thamer; Oliver Bachmann; Dominik Dahl; Elke Maerker; Anna Teigeler; Fausto Machicao; Hans Häring; Michael Stumvoll
Journal:  Metabolism       Date:  2003-06       Impact factor: 8.694

View more
  19 in total

1.  Transcription Factor GLIS3: A New and Critical Regulator of Postnatal Stages of Mouse Spermatogenesis.

Authors:  Hong Soon Kang; Liang-Yu Chen; Kristin Lichti-Kaiser; Grace Liao; Kevin Gerrish; Carl D Bortner; Humphrey H-C Yao; Edward M Eddy; Anton M Jetten
Journal:  Stem Cells       Date:  2016-07-11       Impact factor: 6.277

2.  The association analysis polymorphism of CDKAL1 and diabetic retinopathy in Chinese Han population.

Authors:  Nai-Jia Liu; Qian Xiong; Hui-Hui Wu; Yan-Liang Li; Zhen Yang; Xiao-Ming Tao; Yan-Ping Du; Bin Lu; Ren-Ming Hu; Xuan-Chun Wang; Jie Wen
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

3.  Zinc, insulin, and the liver: a ménage à trois.

Authors:  Thomas V O'Halloran; Melkam Kebede; Steven J Philips; Alan D Attie
Journal:  J Clin Invest       Date:  2013-09-24       Impact factor: 14.808

4.  An integrated approach to identify environmental modulators of genetic risk factors for complex traits.

Authors:  Brunilda Balliu; Ivan Carcamo-Orive; Michael J Gloudemans; Daniel C Nachun; Matthew G Durrant; Steven Gazal; Chong Y Park; David A Knowles; Martin Wabitsch; Thomas Quertermous; Joshua W Knowles; Stephen B Montgomery
Journal:  Am J Hum Genet       Date:  2021-09-27       Impact factor: 11.025

5.  The Krüppel-like protein Gli-similar 3 (Glis3) functions as a key regulator of insulin transcription.

Authors:  Gary T ZeRuth; Yukimasa Takeda; Anton M Jetten
Journal:  Mol Endocrinol       Date:  2013-08-08

Review 6.  GLIS1-3 transcription factors: critical roles in the regulation of multiple physiological processes and diseases.

Authors:  Anton M Jetten
Journal:  Cell Mol Life Sci       Date:  2018-05-19       Impact factor: 9.261

7.  Classification of Type 2 Diabetes Genetic Variants and a Novel Genetic Risk Score Association With Insulin Clearance.

Authors:  Mark O Goodarzi; Nicholette D Palmer; Jinrui Cui; Xiuqing Guo; Yii-Der I Chen; Kent D Taylor; Leslie J Raffel; Lynne E Wagenknecht; Thomas A Buchanan; Willa A Hsueh; Jerome I Rotter
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

Review 8.  Modeling different types of diabetes using human pluripotent stem cells.

Authors:  Essam M Abdelalim
Journal:  Cell Mol Life Sci       Date:  2020-11-26       Impact factor: 9.261

9.  Genetic influences on susceptibility to rheumatoid arthritis in African-Americans.

Authors:  Vincent A Laufer; Hemant K Tiwari; Richard J Reynolds; Maria I Danila; Jelai Wang; Jeffrey C Edberg; Robert P Kimberly; Leah C Kottyan; John B Harley; Ted R Mikuls; Peter K Gregersen; Devin M Absher; Carl D Langefeld; Donna K Arnett; S Louis Bridges
Journal:  Hum Mol Genet       Date:  2019-03-01       Impact factor: 6.150

10.  AGMO Inhibitor Reduces 3T3-L1 Adipogenesis.

Authors:  Caroline Fischer; Annett Wilken-Schmitz; Victor Hernandez-Olmos; Ewgenij Proschak; Holger Stark; Ingrid Fleming; Andreas Weigert; Manuela Thurn; Martine Hofmann; Ernst R Werner; Gerd Geisslinger; Ellen Niederberger; Katrin Watschinger; Irmgard Tegeder
Journal:  Cells       Date:  2021-05-01       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.